Search

for
Search:

GlossaryVemurafenib

medication treats melanoma with BRAF gene mutation

Vemurafenib is a medication used to treat certain types of cancer, specifically melanoma with a mutation in the BRAF gene. It works by inhibiting the activity of the mutated BRAF protein, which helps slow down or stop the growth of cancer cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 104 results

research RASopathic Skin Eruptions During Vemurafenib Therapy

82 citations, March 2013 in “PLoS ONE”

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

research RASopathic Alopecia: Hair Changes Associated with Vemurafenib Therapy

21 citations, March 2015 in “Journal of The American Academy of Dermatology”

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

research Vemurafenib-Induced Pityriasis Amiantacea: A Case Report

9 citations, October 2015 in “Cutaneous and ocular toxicology”

Vemurafenib can cause scalp issues but can be managed without changing the dose.

research Correction: RASopathic Skin Eruptions During Vemurafenib Therapy

4 citations, October 2013 in “PLoS ONE”

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: The Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma

research The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: The Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma

6 citations, April 2013 in “Current Dermatology Reports”

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

View more "vemurafenib" in research →

Community Join

1 / 1 results

community New Treatments, and a Huge Group Buy with Lots of Research

in Research/Science 109 upvotes 1 year ago

A user is organizing a group buy for various compounds aimed at reversing hair loss and gray hair, and improving brain health and fat loss. The user has developed a treatment plan based on extensive research and is inviting others to participate, with the option to choose only the compounds they need.